Medline recalls surgical convenience kits in Class I action over mould risk

Medline Industries is recalling pre-packed surgical convenience kits after some of the sterile applicators inside them were found capable of growing mould. The Food and Drug Administration logged the action in its enforcement database on 23 September 2026 and classified it as Class I, the agency's most serious recall tier, reserved for defects where use could cause serious injury or death [s1].

What is affected

The recall covers two Medline Convenience Kit products, catalogue numbers DYKM1000B and DYKM2187A, with 2,718 kits in the affected quantity and nationwide distribution across the United States [s1]. Three lots are named: lot 24GMD979 of DYKM1000B, and lots 24FBM840 and 24HBK903 of DYKM2187A [s1]. Medline, based in Northfield, Illinois, began the recall itself on 11 August 2026, making this a voluntary, firm-initiated action [s1].

Why a mould contaminant matters

The reason stated in the record is specific. Certain lots of sterile applicators packed in the kits "may contain fungal contamination that may occur under certain environmental conditions, allowing the growth of Aspergillus penicillioides" [s1]. Because those applicators are used to apply skin-preparation products — the antiseptic wash that is meant to sterilise skin before a procedure — a contaminated applicator can carry the hazard to exactly the moment it is supposed to prevent.

The enforcement record spells out the stakes: contamination of skin-preparation products with Aspergillus penicillioides "may lead to serious adverse health consequences, including systemic infection, sepsis, illness, and death" [s1]. Skin antisepsis is a last line of defence against surgical-site infection; an applicator that introduces a fungal organism instead of excluding one inverts the purpose of the step. Aspergillus species are environmental moulds that rarely trouble healthy skin but can cause invasive disease when they reach deeper tissue or a vulnerable patient, which is the pathway a breached skin-prep step can open.

The record is careful about the conditions involved. It describes contamination that "may occur under certain environmental conditions," language that points to fungal growth as a possibility within the affected lots rather than a finding in every kit [s1]. That nuance does not soften the classification: the agency weighs a Class I recall on the severity of what could happen if a defective unit is used, not on how many units are defective, and a mould reaching a surgical field through the antiseptic step is exactly the kind of low-probability, high-consequence hazard the top tier exists to capture [s1].

The wider context

Convenience kits are a quiet fixture of modern operating theatres and procedure rooms: a single sterile tray that gathers drapes, swabs, applicators and small instruments so a team can open one package rather than assemble a procedure by hand. Medline is one of the largest suppliers of these kits in the United States; the company's general-surgery tray was cleared under 510(k) K213481 on 24 May 2022 [s2]. The efficiency of a pre-packed kit is also its exposure: a single contaminated component, replicated across thousands of identical trays, can spread a defect widely and fast, which is part of why a kit recall draws a Class I label [s1].

What to do

This action is directed at hospitals, surgical centres and the clinicians who open these trays, not at consumers; the kits are professional surgical supplies rather than retail products [s1][s2]. A Class I recall sets a concrete task for operating-room and sterile-processing staff: identify whether any of the named lots — 24GMD979, 24FBM840 or 24HBK903 — are on the shelves, quarantine them, and follow Medline's instructions for return or replacement before use [s1].

Red flags that belong with a care team rather than a shelf check include signs of infection after a recent procedure — spreading redness, swelling, fever, or a wound that worsens instead of healing [s1]. Those are reasons to seek medical assessment on their own merits; the recall record documents a contamination hazard and its potential consequences, not any count of patients harmed, and the absence of such a count is not proof that none occurred.

This article describes an FDA enforcement action and is not medical advice. Anyone concerned about a recent operation or a possible infection should speak to the treating clinicians, who can judge symptoms directly and check whether affected lots were involved.

Sources

• FDA Enforcement Report Z-3125-2026: Medline Convenience Kits DYKM1000B and DYKM2187A — U.S. Food and Drug Administration, report date 23 September 2026
• 510(k) K213481: Medline General Surgery Tray, Medline Industries — U.S. Food and Drug Administration, decision date 24 May 2022